EGFR and non-small cell lung carcinoma: The objectives of this study were: 1) to compare EGFR and KRAS mutation status between plasma and tumor tissue in surgically resected TKI-naïve NSCLC; 2) to compare histopathological features between ctDNA shedding and non-shedding tumors; and 3) to evaluate parameters predicting ctDNA shedding.